2 Centre de Référence des Maladies Autoimmunes Rares, Hôpitaux Universitaires de Strasbourg, Strasbourg, France Objective To describe systemic sclerosis (SSc ... anti-topoisomerase I and anti-RNA ...

Introduction: Optic neuritis (ON) is often an early sign of multiple sclerosis (MS), and recent studies show a link between HIF-1 pathway activation and inflammation. This study aimed to determine if ...

Exploring T2DM biomarkers via single-cell RNA sequencing ... and no use of systemic or topical medications. The inclusion criteria for T2DM patients were a glycosylated haemoglobin A1c (HbA1c) level ≤ ...

Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse cutaneous systemic sclerosis ... assessed at 12 ± 3 months, was the ...

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...

Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis (lcSSc), with patients having a high IFN activity presenting worse clinical outcomes.

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

Now, researchers used cryoelectron microscopy (cryo-EM) to elucidate the structure of the Nipah virus polymerase complex ... for both transcription and RNA replication and mutations that have ...

Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...